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Summary.-Cellsfrom anestablished cultureof ahuman astrocytoma were incubated
with normal allogeneic peripheral lymphocytes (PBL) in order to study the natural
killer (NK) sensitivity of the in vitro propagated cell line. A proportion of cells in
culture formed halos, into which lymphocytes did not penetrate. These cells were
successfully cloned and showed a decreased susceptibility to NK cytolysis compared
with the parent line. Both cell lines could be transplanted into athymic nude mice.
The cloned NK-resistant cells underwent a frequent spontaneous regression in nu/nu
mice, despite the fact that when used as targets for nu/nu NK cells in vitro they were
only moderately susceptible. Phase-contrast microscopy of the mass-cultured cells
co-cultivated with lymphocytes suggested that their morphology and ability to form
inpenetrable translucent halos might influence their susceptibility to NK lysis.
Experiments performed on this assumption revealed that quiescent and halo forming
tumour cells were not the primary targets for NK lysis. Cells in mass culture,
although tumorigenic, were thus heterogeneous in respect of susceptibility to NK
attack. These findings might be relevant to the mechanism of immune escape and
tumour heterogeneity in respect of spontaneous cell-mediated lysis.
SPONTANEOUS cytotoxic (ornaturalkiller
(NK)) reactivity of lymphoid cells from
normal donors in the apparent absence of
immunization has been described against a
variety of syngeneic and allogeneic
tumour cell lines (Herberman et al., 1975;
Kiessling et al., 1975). To date the pheno-
menon has been studied most extensively
in man, mice and rats (for review see
Herberman, 1980). NK cells seem to
destroy their targets indiscriminately by
mechanisms yet to be delineated (Pross &
Baines, 1977). In a recent report (Schlager,
1981) the question whether certain meta-
bolic properties of the target cells might
influence their susceptibility to cell-
mediated killing was approached. It was
shown that treatment of the target cells
with drugs and hormones can alter their
sensitivity to cellular attack. The present
investigation was designed to elucidate
some aspects of the susceptibility of a
human glioma cell line and a derived
clone to NK activity. In particular,
attention was focused on glioma cells in
culture, which eluded attack by peri-
pheral lymphoid cells. Understanding of
the "escape" of tumour cells in vitro from
cell-mediated killing might contribute to
a rational approach to therapeutic inter-
vention.
MATERIALS AND INIETHODS
Tumour cells.-A human glioma cell line
was established from a tumour located in the
left cerebral hemisphere. Shortly after exci-
sion, the tumour specimen was washed
several times in phosphate-buffered saline
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(PBS) pH 7-2 and 1mm3 fragments were
seeded on to the bottom of disposable plastic
vessels. Primary and secondary cultures
were maintained in Medium 199 supplemen-
ted with 20% fetal bovine serum (FBS),
100 iu of penicillin/ml and 100 ,ug ofdihydro-
streptomycin/ml (Seromed, Munich) at 37°C
in an atmosphere of5% C02 in air.
Human peripheral lymphocytes.-Lympho-
cytes from healthy donors were separated
from heparinized blood on Ficoll-Isopaque
(Pharmacia, Sweden), centrifuged for 40 min
at 900 g, followed by incubation in Falcon
plastic culture flasks in RPMI medium
(Seromed, Munich) for 30 min at 370C and
passed through a nylon-fibre column, (Vose
et al., 1977). The nylon column passed cells
contained 86 +5% sheep erythrocyte rosette-
forming cells (RFC) and 3+1% erythrocyte
antibody RFC (FcyR cells). Contamination
with cells of obviously non-lymphocyte mor-
phology represented 2%.
Preparation of effector cells from nu/nu
BALBIc mice.-BALB/c mice were killed by
cervical dislocation and the spleen cells
squeezed through a stainless-steel mesh into
RPMI medium, supplemented with 2% heat-
inactivated FBS and antibiotics. The cells
were freed from erythrocytes by incubation
in Tris-buffered (pH 7.2) 0.83% NH4Cl and
washed once in supplemented RPMI medium.
After treatment with carbonyl iron powder
(200 mg for 10 ml suspension, Fluka, Buchs,
Switzerland) for 2-3 h at 370C and separation
of the phagocytic cells with a magnet,
the remaining cells were washed x 2 with
medium and resuspended in RPMI medium
containing 10% serum.
Cell-cloning protocol.-Mass cultures were
established and the glioma lines were propa-
gated in vitro by splitting the cells at a ratio
of 1:3 twice a week. To 105 glioma cells
growing in hydrophilic Petriperm dishes, a
100-fold excess ofnormal peripheral lymphoid
cells was added and incubated under standard
conditions overnight. The cultures were then
examined by phase-contrast microscopy
(Diavert, Zeiss) for glioma cells forming a
halo, into which no lymphoid cells penetrated.
These cells, were pickedup bygentle agitation
with a micropipette and transferred into
Costar wells with a micropipette manipulator.
One cell was seeded into each well, and 20 ,ul
of conditioned Medium 199 supplemented
with 20% human serum (AB, Rh+, Seromed,
Munich) were added. The medium was
changed when the clonal lines reached semi-
confluence, which did not occur before 2-3
weeks after the cloning procedure.
Tumorigenicity.-Thymus-deficient male
mice on a BALB/c background (nu/nu), 3-4
weeks old, were injected s.c. with 106 cells of
the mass culture and with 105-106 cells of
the cloned sub-line, respectively.
Cytotoxicity assay.-A 14C-nicotinamide
(14C-NA) assay was carried out with minor
modifications (Kurth & Medley, 1975). Five-
10 x 104 glioma cells were seeded in each well
of Costar plates and incubated under stan-
dard conditions for 18 h with 15 tuCi 14C-NA
(sp. act. 10 mCi/mmol, NEN Chemicals
GmbH, Dreieich). At the end of the incuba-
tionperiod, unincorporated label wasremoved
by repeated washings of the cells with
medium. Afterwards an appropriate number
of lymphoid cells was added to the cultures
to give various target:effector cell ratios in a
final volume of 200 ,ul. Tests were performed
in triplicate. The lymphoid cells were co-
cultivated with the glioma cells for 4 h and
an aliquot of the supernatant was analysed
for 14C-NA. Non-specific release of 14C-NA
was determined from target cells incubated
with medium only and maximum release of
14C-NA was determined by lysis of the cells
with 0.5% Triton X-100. Percentage cyto-
toxicity was calculated from the formula:
14C-NA release (test)
-14C-NA nonspecific release 100
14C-NA maximum release x
-14C-NA nonspecific release
Cytotoxicity assay and hyaluronidase treat-
ment oftargets.-In an attempt to remove the
halos, 5 x 104 cells were seeded in each well
ofCostar tubes and incubated under standard
conditions for 18 h with 15 ,tCi 14C-NA; un-
incorporated label was removed by repeated
washings. To the 14C-NA-labelled glioma cells
10 iu/mlhyaluronate4-glyeano-hydrolase (bo-
vine testes, Serva, Heidelberg, G.F.R.) was
added and incubation continued for 20 min at
37°C. Thereafter, the enzyme was removed by
washing and the cells tested for their ability
to form halos using peripheral lymphocytes
from healthy donors as indicators. Cell-
mediated lysis was also monitored in a 4h
cytotoxicity assay.
Arrest ofcyclingcells.-Exponentially grow-
ing tumour cells were rendered quiescent by 3
different media manipulations: (i) glutamine
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deletion; (ii) reduction ofserum concentration
to 0.5%; or (iii) addition of N, N-dimethyl-
carbamoylmethyl 4-(4-guanidinobenzoyloxyl)
phenyl acetate methanosulphonate (1 mg/ml)
(Sanol Schwarz GmbH., Mohnheim G.F.R.:
Foy II) was added to the culture medium.
DNA synthesis was measured by [3H]-dT
incorporation. Tumour cells were adjusted to
106 cells/ml in glutamine or serum-depleted
culture medium. Ten ,uCi of [3H]-dT/25 ,ul
were added to each culture tube. At 4h
intervals the cultures were flushed andwashed
with cold PBS and precipitated with cold
10% TCA in the presence of a small amount
of protein carrier. TCA precipitates were
dissolved in NCS (Amersham/Searle Corp.,
Arlington Heights, Ill., U.S.A.) and counted
in Omnifluor toluene (New England Nuclear,
Boston, Mass., U.S.A.). Protein synthesis
was measured using the same procedure
except that 14C-leucine (5 Fxl/ml) was added
to the cells.
After 35-40 h in depleted media, glutamine
and serum were restored and absolute cell
numbers of vital cells were counted in a
haemacytometer by the trypan-blue exclu-
sion method; the number obtained was
compared with that initially seeded.
RESULTS
Cell cultures
Two-3 days after seeding the primary
tumour, a pleomorphic glioma, cells grew
out from the explants. More cytoplasm
was evident in the cells of this neoplasm
than in normal glial cells, and stroma was
densely fibrillated. Some areas of the
tumour showed great variation in size and
shape of the cells, with giant and multi-
nucleated forms and sometimes bizarre
mitosis; the neoplasm was classified as a
grade 2-3 astrocytoma. The cells in mass
culture consisted of populations of mixed
morphology, but slender bipolar cells
dominated multipolar flat cells, at least at
low passage numbers. Cells which eluded
lymphocytic attack were cloned from
the 8th and 15th passages respectively.
These tumour cells were surrounded by a
large transparent halo which the lympho-
cytes were unable to penetrate. The clones
were composed mainly of spherical giant
cells, the cytoplasm of which appeared to
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expand in a veil-like fashion at the cell
periphery, where the nucleus was situated.
The clone, when successfully established,
grew very slowly, never went beyond the
8th-12th passage level and did not sur-
vive beyond 3-4 months. The cells never
had a fibroblast- and/or stellate-like
appearance.
Escapefrom lymphocytic attack
Phase-contrastmicroscopyrevealed that
certain cells in the mass culture eluded
cytolysis, even in cultures comprising
excessive allogeneic peripheral lymphoid
cells (Fig. 1). After culture for more than
4 h, 5-15% of the mass culture cells
prevented lymphocytes from approaching
their cell membranes. This proportion
increased to 60-75% in the clonal line,
and the phenomenon was observed until
the 20th passage in the mass culture.
Relative susceptibility of mass culture and
the clone line at various passage levels
Lymphocytes were either cocultivated
with cells from the mass culture or from
the clonal line for the measurement of
cytotoxicity. At any passage number, the
mass culture was more susceptible to lysis
by a factor of 5 than the cells ofthe clonal
line (Fig. 2). No significant difference how-
ever could be discerned between the
passage levels of the respective cultures
and susceptibility to lysis.
Effect of enzyme treatment on the halos
The ability of lymphocytes to lyse cells
of the parental and clonal lines was
measured after hyaluronidase treatment
ofthe target cells (McBride & Bard, 1979).
The results of 3 separate experiments are
presented in the Table. Hyaluronidase
treatment enhanced the 14C-NA release
of both cell lines, but the effect was most
remarkable upon the clonal cell line. The
cytotoxicity of lymphocytes against the
latter was increased cytotoxicity by a
factor of 10, and was associated with
decreased halo formation, checked under
the microscope.
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FIG. 1.-Cells in a glioma mass culture, eluding lymphoid cell attack. Note the halos which were
formed by distinct cells even in cultures overcrowded with lymphoid cells (A. 7th passage, B,
14th passage). x 450. Phase contrast.
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against glioma cells. Each circle represents
the mean percentage cytotoxicity against
target cells in triplicate cultures of one
experiment. The cells of the clonal line
showed a highly significant suppression to
NK sensitivity, P < 0 -01.
TABLE.-Effect of hyaluronidase on halo
formation and cytotoxicity ofparental and
cloned glioma cell lines
Cell line
Parent,al
Parental
Clonal
Clonal
Halo
Hyaluronidase Lysis % formation
Witlhout 17 + 2 +
10 liu/ml 27+6 (+) -
Without 7+ 2 + + +
Ioiu/ml 68+12 +
Cytotoxicity experiments were performed in tri-
plicate at an effector target: cell ratio of 20: 1, using
peripheral blood lymphocytes from healthy donors
as effector cells. The ability of the tumour cells to
form transparent halos was evaluated by phase-
contrast microscopy. After a 20min incubation
period with hyaluronidase and after a further lh
period the cells were briefly fixed in PBS-buffered
glutaraldehyde (pH 7 2) and photographed using a
conventional inverted microscope; a sequence of
photographs was examined for halo formation. In
parallel test, cytotoxicity with and without hyaluro-
nidase treatment oftargets wasmeasured as described
in Materials and Methods.
1ytolysis ofspleen effector cells derivedfrom
nu/nu BALB/c mice
Cytotoxicity against cells of the mass
culture and the clone was tested with
spleen cell effectors from 12-week-old
nu/nu BALB/c mice. These were only
minimally cytotoxic for the clone but
the same preparation showed a higher
cytotoxicity for the parental cells (Fig. 3)
in common with human lymphocytes.
Modification of target-cell susceptibility by
interruption of the cell cycle
Lymphocytes were incubated in a cyto-
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FIG. 3. NK activity of spleen cells from
athymic mice against the mass-culture
cells (O- O-) and the clonal line
0*-0-0). Each circle represents the
mean percentage of cytotoxicity against
target cells derived from triplicate cultures.
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FIG. 4. NK activity of human lymphocytes
against quiescent and proliferating cells.
Mass culture cells were shifted into Go-
phase and used as target cells. Cells main-
tained in low serum concentration or in
the absence of L-glutamine were almost
insusceptible to NK damage (O O O)-
Cells, treated by a synthetic protein inhibi-
tor (FOY II) were lysed to a moderate
extent by NK cells (0 0 0) compared
to unmanipulated proliferating cells
(A A A).
toxicity assay either with quiescent or
proliferating cells from the mass culture.
Fig. 4 shows that lysis of these cells,
manipulated by 3 different procedures
into GO-phase was significantly blocked.
However, the same cells when allowed
to continue unimpeded in cycle, showed
a higher susceptibility to lysis. These
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experiments suggest that quiescent cells
are not the primary targets for NK cells.
Tumourigenicity
After a latency period of 10-12 days
tumours developed at the inoculation sites
in the nude mice. The time for tumour
development depended partly on the
passage level of the culture and partly on
the age of the mice. In general, cells from
the mass culture developed a palpable
tumour earlier (' 14 days) than did the
cloned cells ( 3 weeks). Tumour takes
were also influenced by the age of the
mice, because in some instances spontan-
eous tumour regression occurred after 4-5
weeks, when the neoplasm had reached a
measurable size; this phenomenon was
particularly apparent with cells from the
cloned line. Empyema, as a pseudo-
tumorigenic feature, was excluded by
fine-needle biopsy.
DISCUSSION
It is a reasonable assumption that the
cells engaged in these experiments were
tumour cells, since they fulfil the criterion
of autonomous growth when injected into
thymus-deficient mice. The tumorigenicity
of the cloned cells declined with time, as
juldged from the increasing latency period
and the increased number of spontaneous
regressions. Cytotoxicity experiments,
however, were performed when both cell
lines were able to form solid tumours in
the nude mouse. The reason why the
cloned cells never survived beyond the
12th passage in-vitro is not clear but may
be associated with the mode of growth
(permanently spherical) and incomplete
differentiation.
Studies on the expression of NK-
relevant recognition structures in human
tumours using cold target competition
assays have been given conflicting results
(Ortaldo et al., 1977; Mantovani et al.,
1980). Although the cells of the clonal
line did not pass a certain passage level,
susceptibility to NK lysis did not change
during the life-span of the in vitro propa-
gated clonal line; this might suggest that
the cells of the clonal line did not
express NK-recognition structures, which
are closely linked to the cell replication.
Phase-contrast microscopy of the mass
culture, in which identifiable single cells
create a halo, suggests that these cells
produce and release mediator(s) into their
vicinity, forming a diffusion gradient into
which lymphoid cells are prevented from
migrating. A similar exclusion phenome-
non was described by McBride & Bard
(1979) for a series of chemically induced
and virus-transformed tumour cell lines.
These authors regarded these barriers as a
protective mechanism preventing immune
effector cells from establishing the contact
with tumour cells in vitro which is an
essential prerequisite for cell-mediated
lysis. Until now, the nature of the sub-
stances implicated in such self-defence and
released by the target cells in culture
remained unclear. The hyaluronidase ex-
periments, however, as performed origin-
ally by McBride & Bard (1979) and
repeated here suggest that part of the
process involves secretion of hyaluroni-
dase-sensitive material into the vicinity
of the tumouir. There is however an
alternative interpretation of the cyto-
toxicity results. It has been shown that
some target cells are more susceptible to
cell-mediated immune killing in certain
phases of the cell cycle (Berke, 1980;
Leneva & Svet-Moldavsky, 1974; Zanker
& Blumel, 1981; Zanker et al., 1981b). It
could be argued that a fraction of cells in
an unsynchronized cell population arrests
in a "hyposusceptible" stage due to the
configuration of the cell membrane (fluid-
ity, permeability) (Schlager & Ohanian,
1979, 1980). Our results substantiate the
view that these biological phenomena
need to beevaluated byindependent meth-
ods in order to develop accurate interpreta-
tion of the various findings.
On transplantation into nuide mice, the
cloned NK-resistanit cells exhibited a
longerlatency andhigherincidence ofspon-
taneous tumour rearession than the paren-
tal line containing NK-sensitive elements.
622CLONED GLIOMA CELLS RESISTANT TO NK CELLS 623
In order to clarify this apparent contra-
diction mass-cultured and cloned cells
were arrested in the quiescent phase and
used afterwards as target cells. It was
found that quiescent cells were less sus-
ceptible to NK lysis by nu/nu NK cells
or human lymphocytes than proliferating
cells. Furthermore, proliferating NK-resis-
tant cloned cells were less susceptible to
nu/nu NK cells than proliferating mass-
cultured cells. Both experimental results
support the following working hypothesis
for the "escape" of target cells: growth of
initially transplanted NK-resistant cells
was generally slow because the greater
proportion of cells remained in a quiescent
phase and were not targets for nu/nu NK
cells. The long latency period for tumour
development supports this view, and fur-
ther evidence is provided by the low in
vitro cytotoxicity of nu/nu NK cells
against the NK-resistant cloned cells.
Spontaneous tumour regression, as seen
in nu/nu mice inoculated with transplant-
able NK-resistant cloned cells, is thuii
primarily not attributable to nu/nu NK
cells, but to another cell-mediated and/or
humoral immune response.
Recently similar disparity between in
vitro data on susceptibility to murine NK
cells and in-vivo data on the heterotrans-
plantability to nude mice of diploid
human lymphoblastoid and Burkitt lym-
phoma celllines were reported (McCormick
et al., 1981). These authors also assumed
that immune effector mechanisms other
than a direct cytotoxic action by NK cells
may have been the decisive factor in the
experiments.
The nature of NK cells is of particular
interest, because it is possible that these
cells maybe responsible forthe destruction
oftransformed cellsbeforetheconventional
immune system is triggered by the expres-
sion of tumour-associated and/or tumour-
specific antigens. The "escape" of a meta-
stasizing variant of a chemically induced
lymphoma from a DBA/2 mouse was
recently reported (Bosslet & Schirrmacher,
1981). The variants were specifically resis-
tant to lysis by anti-tumour cytolytic T
lymphocytes. Our experiments along simi-
lar lines with NK cells and show that
tumour cells may arise with in a neoplasm
which are also resistant to NK activity;
the resistant phenotype of the cloned line
remained stable over prolonged passage.
Our experimental results suggest that
heterogeneity of the mass culture mirrors
the neoplasm in 8itU, with respect to NK
susceptibility. In vivo it might be envi-
saged that those cells which are not the
primary target of NK activity could be
lysed by antibody-dependent cytotoxic
lymphocytes (ADCC), specific T lympho-
cytes, and/or by the humoral immune
system. If these cytotoxic manoeuvres
fail and the transformed cells evade
immune barriers, continuous tumour
growth results. Experiments are in pro-
gress to determine whether cloned lines,
which have eluded NK cells' attack, can
be killed by glioma-cell-directed cytotoxic
antibodies, detectable in astrocytoma
patients (Kornblith et al., 1979), the titre
of which can be enhanced by chemical
modifications of cell-surface antigens on
the basis of animal experiments (Zanker
et al., 1981a).
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